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Objectives: The aim of the present study was to use a voxel-based magnetic resonance
imaging method to investigate the neuroanatomical characteristics in subjects at high risk
of developing psychosis compared with those of healthy controls and first-episode schizo-
phrenia patients.
Methods: This study included 14 subjects with at-risk mental state (ARMS), 34 patients
with first-episode schizophrenia, and 51 healthy controls. We used voxel-based morphom-
etry with the Diffeomorphic Anatomical Registration through Exponentiated Lie Algebra
tools to investigate the whole-brain difference in gray matter volume among the three
groups.
Results: Compared with the healthy controls, the schizophrenia patients showed signif-
icant gray matter reduction in the left anterior cingulate gyrus. There was no significant
difference in the gray matter volume between the ARMS and other groups.
Conclusion:The present study suggests that alteration of the anterior cingulate gyrus may
be associated with development of frank psychosis. Further studies with a larger ARMS
subjects would be required to examine the potential role of neuroimaging methods in the
prediction of future transition into psychosis.
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INTRODUCTION
Neuroimaging studies have demonstrated subtle but widespread
brain structural alterations, such as volume reduction of fronto-
temporo-limbic regions as well as enlarged lateral and third ven-
tricles, in first-episode schizophrenia (Steen et al., 2006; Vita et al.,
2006; Ellison-Wright et al., 2008), which are not due to illness
chronicity and antipsychotic medication. Recent prospective lon-
gitudinal magnetic resonance imaging (MRI) studies, including
our own data showing progressive gray matter reduction of the
temporal region (approximately 2–3% per year) (Takahashi et al.,
2010, 2011), further revealed progressive brain structural change
and its relationship to clinical course or outcome in first-episode
schizophrenia (Andreasen et al., 2011). These longitudinal find-
ings might be consistent with the clinical observation that a long
duration of untreated psychosis (DUP), which could lead to severe
brain pathological changes during the early illness stage (Lappin
et al., 2006; Takahashi et al., 2007), is related to poor outcome of
schizophrenia patients (Marshall et al., 2005; Perkins et al., 2005).
Examining potential neurobiological markers that predate the
onset of psychosis might lead to appropriate early intervention and
thus prevent deterioration of social function and the progression
of structural brain alterations.
It is not yet clear at which illness stage brain abnormalities occur
in schizophrenia. Subjects with at-risk mental state (ARMS), who
exhibit prodromal-like symptoms and have an increased risk of
developing psychosis (Yung et al., 2003), might share disease vul-
nerability as well as brain morphological changes with patients
with overt schizophrenia. Subjects with ARMS are heterogeneous
on the basis of their outcome, as only about 36% of them develop
psychosis during 3-year follow-up (Fusar-Poli et al., 2012). Previ-
ous MRI studies using voxel-based morphometry (VBM), which
allows automated whole-brain analysis, revealed more severe gray
matter reduction predominantly in the fronto-temporo-limbic
regions in ARMS subjects with later transition than in those
without (Pantelis et al., 2003; Borgwardt et al., 2007; Fusar-Poli
et al., 2011). More specifically, Fornito et al. (2008) revealed that
baseline differences in the anterior cingulate cortical thickness dis-
tinguished between ARMS with and without later transition, but
they did not directly compare ARMS subjects and patients with
overt psychosis.
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This voxel-based MRI study aimed to investigate the nature
of neuroanatomical abnormalities in high-risk subjects com-
pared with both healthy controls and first-episode schizophrenia
patients. On the basis of previous neuroimaging findings, we pre-
dicted that both first-episode schizophrenia and ARMS subjects,
especially those with later transition, would show brain morpho-
logical changes in fronto-temporo-limbic regions compared with
healthy subjects.
MATERIALS AND METHODS
PARTICIPANTS
Fourteen individuals (10 males and 4 females) defined as ARMS for
psychosis were recruited from the Consultation Support Service in
Toyama (CAST), which was launched in 2006 as a specialized clin-
ical setting to study and treat young persons (aged 15–30 years)
at risk of developing psychosis (Mizuno et al., 2009). The sub-
jects with ARMS were diagnosed according to the Comprehensive
Assessment of ARMS (CAARMS) (Yung et al., 2004); they were
characterized by one or more of the following: (1) attenuated psy-
chotic symptoms; (2) brief, limited intermittent psychotic symp-
toms with spontaneous resolution; or (3) family history of psy-
chosis in first-degree relatives or a personal history of schizotypal
personality disorder accompanied by a decline in general func-
tioning. Their clinical symptoms were assessed using the Scale for
the Assessment of Negative Symptoms (SANS) (Andreasen, 1983)
and the Scale for the Assessment of Positive Symptoms (SAPS)
(Andreasen, 1984) at the time of scanning. Eleven ARMS subjects
were neuroleptic-naïve at scanning, but two subjects were treated
with atypical neuroleptics and one was receiving sulpiride. Their
duration of medication use was shorter than 2 weeks for atypical
neuroleptics and shorter than 6 months for sulpiride. They were
also receiving benzodiazepines (N = 2), antidepressants (N = 1),
and tandospirone (N = 3).
Thirty-four patients with first-episode schizophrenia (20 males
and 14 females), who met the ICD-10 research criteria (World
Health Organization, 1993), were recruited from the inpatient
and outpatient clinics of the Department of Neuropsychiatry,
Toyama University Hospital. The patients were diagnosed fol-
lowing structured clinical interviews by experienced psychiatrists
using the Comprehensive Assessment of Symptoms and History
(CASH; Andreasen et al., 1992). Their durations from manifes-
tations of overt psychotic symptoms were shorter than 1 year.
Their clinical symptoms were assessed using SANS and SAPS at the
time of scanning. Thirty-three patients were receiving neurolep-
tic medication at the time of scanning; 2 patients were treated
with typical neuroleptics, 26 were receiving atypical neurolep-
tics, 5 were taking both typical and atypical neuroleptics, and
1 patient was neuroleptic-free. They were also receiving anti-
cholinergic drugs (N = 8), benzodiazepines (N = 9), antidepres-
sants (N = 1), carbamazepine (N = 1), and lithium carbonate
(N = 3).
Exclusion criteria for ARMS subjects and schizophrenia
patients were other neurological diseases, past or present regu-
lar alcohol abuse, and/or consumption of illicit drugs as reported
by the study participants and/or the patients’ records, as well as
past head trauma with loss of consciousness or electro-convulsive
treatment.
The control subjects consisted of 51 healthy volunteers (30
males and 21 females) recruited from members of the commu-
nity, hospital staff, and university students. They were given a
questionnaire consisting of 15 items concerning their personal (13
items; including a history of obstetric complications, substantial
head injury, seizures, neurological or psychiatric diseases, impaired
thyroid function, hypertension, diabetes, and substance use) and
family (2 items) histories of illness. They did not have any personal
or family history of psychiatric illness in their first-degree relatives.
This study was approved by the ethics committee of Toyama Uni-
versity. Written informed consent was obtained from all subjects
prior to study participation.
MRI ACQUISITION
Magnetic resonance images were obtained by utilizing a 1.5-T
Magnetom Vision (Siemens Medical System, Inc., Erlangen, Ger-
many) with a three-dimensional gradient-echo sequence FLASH
(fast low-angle shots) yielding 160–180 contiguous T1-weighted
slices of 1.0-mm thickness in the sagittal plane. The imaging para-
meters were as follows: TR= 24 ms; TE= 5 ms; flip angle= 40˚;
field of view= 256 mm; and matrix size= 256× 256 pixels. The
voxel size was 1.0 mm× 1.0 mm× 1.0 mm. All scans in the patient
and control groups were acquired in the same system with the same
protocol.
MRI DATA PROCESSING
All T1-weighted MRI data were first converted from the Dicom
format to the NIFTI format and then processed using Statistical
Parametric Mapping 8 (SPM8, Wellcome Institute of Neurology,
University College London, UK, http://www.fil.ion.ucl.ac.uk/spm)
running under MATLAB R2008b (The MathWorks Inc., USA).
The unified segmentation model consisting of spatial normal-
ization, bias field correction, and tissue segmentation was per-
formed in order to improve the quality of data preprocessing (Ash-
burner and Friston, 2005). Tissue probability maps were registered
to the subject’s data, and final tissue probability maps were derived
from prior maps with the use of a combination with tissue prob-
abilities based on the voxel intensity. To make the processed data
more accurate, we used the Diffeomorphic Anatomical Registra-
tion through Exponentiated Lie Algebra (DARTEL) (Ashburner,
2007; Ashburner and Friston, 2009; Klein et al., 2009) tool in
SPM8. DARTEL is not integrated into the segmentation model and
requires the input of gray matter tissue maps produced by unified
segmentation. This algorithm records inter-subject images using
diffeomorphisms, which preserve the object properties through
deformations, twistings, and stretchings, and archives a more accu-
rate inter-subject registration. Because DARTEL produces a more
accurate registration, it improves the sensitivity of finding and
localizing differences between groups in terms of the gray matter
volume. Registered tissue maps were transformed to the stereo-
tactic space of the Montreal Neurological Institute (MNI) and
multiplied with the Jacobian determinants of the deformations in
order to preserve the volume of tissue in each structure. Finally,
the modulated, warped tissue maps were then written with an
isotropic voxel resolution of 1.5 mm3 and smoothed with a 10-mm
Full-Width Half-Maximum (FWHM) Gaussian kernel (Salmond
et al., 2002; Jones et al., 2005).
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STATISTICAL ANALYSIS
Demographic data
Group differences in age, educational level, parental educational
level, and intracranial volume (ICV) were examined with one-way
analysis of variance (ANOVA) and post hoc Scheffé’s test. Group
differences in terms of gender were tested with Chi-square tests.
The level of statistical significance was defined as p< 0.05 (two-
tailed). Statistical analyses were performed with Statistica, version
06J for Windows (StatSoft Japan Inc., Tokyo, Japan).
Voxel-based analysis of gray matter volume
Gray matter volume differences between the ARMS subjects, schiz-
ophrenia patients, and healthy controls were analyzed using two-
sample t -tests implemented in the general linear model approach
of SPM8 with age and ICV as nuisance covariates. We used clus-
ter level inference (the extent of contiguous clusters of individ-
ual significant voxels) for determination of statistical significance
(Meisenzahl et al., 2008). Because cluster size distribution varies
according to local smoothness, the cluster sizes in this study were
adjusted according to the local smoothness within the framework
of the Random Field Theory (RFT) (Worsley et al., 1999; Hayasaka
et al., 2004). Our statistical inference was performed at the clus-
ter level by assessing the SPM{t} images by the non-stationary
cluster extent correction (Hayasaka et al., 2004), which has been
reported to be robust when MRI experiments fulfill (1) degrees
of freedom> 30 and (2) image smoothness (FWHM)> 3 × voxel
sampling resolution (Hayasaka et al., 2004), as in this study. The
cluster-defining threshold was set to p< 0.001. Then, a family-
wise error-corrected (FWE) cluster size threshold of p< 0.05
was applied to account for multiple comparisons of the results
(corrected cluster sizes). Finally, cluster sizes were adjusted for
smoothness non-uniformity using the VBM8 toolbox (Gaser,
2009), which implements the methodology of Hayasaka et al.
(2004).
Voxel coordinates are given as an indication of location in a
standardized brain. Voxels were localized in MNI space and trans-
formed into Talairach and Tournoux coordinates (Talairach and
Tournoux, 1988).
RESULTS
DEMOGRAPHIC DATA
Table 1 shows demographic and clinical data of the subjects in this
study. Groups were matched for gender, parental education, and
ICV. However, the controls (p< 0.001) and schizophrenia patients
(p< 0.001) were older than the ARMS subjects. The controls had
a higher educational level than the other two groups (p< 0.001)
and the schizophrenia patients had a higher educational level than
the ARMS subjects (p= 0.004).
VOXEL-BASED ANALYSIS OF GRAY MATTER VOLUME
Compared with the healthy controls, the schizophrenia patients
showed significant gray matter volume reduction in the left ante-
rior cingulate gyrus (FWE-corrected p= 0.047) (Figures 1 and 2;
Table 2). There was no difference between the ARMS subjects and
the schizophrenia patients or the healthy controls.
DISCUSSION
In this study, we performed VBM analyses using the DARTEL
method to investigate gray matter change in early psychosis. In
comparison to the healthy controls, first-episode schizophrenia
patients showed significant gray matter reduction in the left ante-
rior cingulate gyrus, but the ARMS subjects showed no significant
difference in gray matter volume. This negative finding may be
partly related to the heterogeneity of the ARMS subjects, as those
with later transition to psychosis had a similar distribution of
the cingulate gyrus gray matter volume to that in first-episode
schizophrenia patients (Figure 2). These preliminary results are
partly consistent with previous findings by Fornito et al. (2008),
who reported that baseline differences of anterior cingulate gyrus
distinguish between high-risk individuals who do and do not
subsequently develop overt psychosis.
Neuroimaging studies comparing schizophrenia patients to
healthy controls have shown evidence of morphological change in
the anterior cingulate gyrus (Ellison-Wright et al., 2008; Shepherd
et al., 2012). Gray matter volume reduction (Salgado-Pineda et al.,
2003; Koo et al., 2008; Meisenzahl et al., 2008; Leung et al., 2011)
and reduced cortical thickness (Schultz et al., 2010) in the anterior
Table 1 | Clinical and demographic characteristicsa.
Characteristic ARMS
(N =14)
Schizophrenia
(N =34)
Healthy control
(N =51)
Gender (male/female) 10/4 20/14 30/21
Age (years)b 18.9 (1.4) 24.7 (5.5) 23.9 (1.8)
Educational level (years)c 11.6 (1.4) 13.5 (2.0) 16.0 (1.7)
Parental educational level (years) 13.7 (1.4) 13.3 (1.7) 14.1 (2.2)
Age at onset (years) N/A 23.3 (5.4) N/A
Duration of medication (months) 0.43 (1.6) 1.7 (1.8) N/A
Drug (mg/day, haloperidol equivalent)d 0.55 (1.1) 6.3 (6.5) N/A
Intracranial volume (cm3) 1557.8 (130.0) 1602.1 (150.7) 1573.6 (143.0)
aValues given as mean (SD).
bSignificant difference between groups.
cSignificant difference between groups.
dThe different typical and atypical neuroleptic dosages were converted into haloperidol equivalents using the guidelines of Toru (2001).
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FIGURE 1 | Group difference of the gray matter between the
schizophrenia patients and the healthy controls.The cluster in which the
schizophrenia patients show gray matter reduction is located in the left
anterior cingulate gyrus.
FIGURE 2 | Scatter plots of gray matter volume of the peak coordinate
at the left anterior cingulate gyrus that revealed the difference
between schizophrenia patients and controls.The ARMS subjects were
classified into three groups according to clinical outcome (square: ARMS
who developed psychosis, triangle: ARMS with unknown outcome, circle:
ARMS without transition to psychosis). *p<0.05.
cingulate gyrus have been revealed by MRI studies in first-episode
and neuroleptic-naïve patients to minimize the influence of neu-
roleptic medication or chronicity of the illness. In this study, gray
matter volume reduction in the left anterior cingulate gyrus in
the schizophrenia patients had no relationship with any effects of
medication (data not shown).
Table 2 |Talairach coordinates for regions of reduced gray matter
volume in the schizophrenia patients compared to the healthy
controls.
Region Voxel Peak coordinate T p
x y z
lt. anterior cingulate gyrus 631 −11 42 8 3.82 0.047
One major aim of high-risk studies for psychosis has been to
identify clinical and neurobiological predictors of future transition
to psychosis, which would allow specific and targeted preventive
strategies (McGorry et al., 2006); indeed, previous neuroimag-
ing studies have identified such predictive markers. The VBM
study by Pantelis et al. (2003) revealed the association between
later transition and gray matter reduction in temporal and frontal
regions predominantly in the right hemisphere and cingulate gyrus
bilaterally in clinical high-risk subjects, which was largely repli-
cated in an independent high-risk cohort (Borgwardt et al., 2007).
Recent multi-center (Mechelli et al., 2011) and meta-analytic
(Smieskova et al., 2010; Fusar-Poli et al., 2011) MRI studies on
large numbers of high-risk subjects generally supported the asser-
tion that brain morphological changes in the fronto-temporo-
limbic regions, including the cingulate gyrus, already exist prior
to the onset of psychosis. Although our data are clearly limited
by the small sample size as discussed below, the distribution of
the anterior cingulate gray matter volume (Figure 2) implies
that ARMS subjects with later transition may have morpholog-
ical changes of the cingulate gyrus to the same degree as those
with overt schizophrenia. There has been debate about the risk-
benefit ratio of antipsychotic treatment in prodromal patients
(Woods et al., 2007; Weiser, 2011). However, given the hypoth-
esized active brain pathology in the early phases of psychosis,
which could affect the subsequent course of the illness (Birch-
wood et al., 1998), and the potential ameliorating effects of atyp-
ical antipsychotics for brain structural abnormalities (Lieberman
et al., 2005; Girgis et al., 2006), intervention before the expres-
sion of frank psychosis may reduce neurobiological deterioration
as well as the transition rate to psychosis (McGorry et al., 2002;
McGlashan et al., 2006), especially in subjects with neurobiological
risk markers.
The sample size of the current ARMS group (especially
those who later developed psychosis) was small and some
individuals dropped out during clinical follow-up (N = 4,
unknown outcome group). Significant group differences in age
(ARMS< schizophrenia and controls) might also have biased
our results, although we used age as a controlling factor in all
imaging analyses. In contrast to our prediction, we did not find
significant brain morphological changes in the ARMS subjects,
potentially due to the small sample size. It was also not possi-
ble to examine the relationship between brain morphology and
clinical outcome (later transition) in our ARMS subjects statis-
tically. In addition, direct comparison between the three groups
using the ANOVA model with age and ICV as covariates failed
to replicate significant group difference in the cingulate gyrus
gray matter volume. Thus, further study with a larger well-defined
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sample is required to replicate and expand the current preliminary
results.
In summary, the present study demonstrated significant gray
matter reduction of the anterior cingulate gyrus in first-episode
schizophrenia. We also suggested the possibility that such morpho-
logical change may exist prior to the onset of psychosis in some
individuals, implying the potential role of neuroimaging methods
in the prediction of future transition and effective intervention for
high-risk subjects.
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